Editor's Note The US Food and Drug Administration (FDA) designated Getinge’s recall of Vaporizer Sevoflurane Maquet Filling and Sevoflurane Quick-Fil and Philips’ recall of Tack Endovascular Systems as Class 1s, the most severe category indicating serious risk of injury or death. The Getinge recall is an expansion of a 2024…

Read More

Editor's Note A new genetic testing tool could allow surgeons to accurately identify cancer cells in real time during brain surgery, potentially improving surgical outcomes and reducing cancer recurrence, NYU Langone Health System announced.  According to a February 25 press release, the Ultra-Rapid droplet digital PCR (UR-ddPCR) technique identifies cancer…

Read More

Editor's Note Insufficient awareness of drug interactions with hormonal contraceptives (HCs) among anesthesia providers could lead to unintended pregnancies and preventable health consequences, according to survey published in Anesthesia & Analgesia. Physician’s Weekly covered the news February 27. The article specifically cites sugammedex and aprepitant, both of which are widely…

Read More

Editor's Note For the first time in Canada, surgeons aim to restore a patient’s sight by gluing a lens into a removed tooth, temporarily implanting the structure into the cheek to develop a tissue lining, then sewing it onto the front of eye three months later. CTV News reported on…

Read More

Editor's Note A cohort study published February 24 in JAMA Pediatrics found that prophylactic antibiotics reduced the odds of surgical site infections (SSIs) by 72% in children undergoing cholecystectomy for uncomplicated cholelithiasis. However, extended-spectrum antibiotics offered no additional benefit over cefazolin, suggesting that simpler prophylaxis protocols could optimize outcomes while…

Read More

Editor's Note A February 21 article in Modern Healthcare details how surgical robots are delivering faster procedures, improving patient outcomes, and boosting hospital profits. As detailed in the article, the global surgical robotics market has quadrupled since 2015, growing from $800 million to approximately $3 to $3.5 billion in 2023…

Read More

Editor’s Note The US Food and Drug Administration (FDA) has designated Boston Scientific Corporation’s recall of Accolade Pacemaker devices a Class 1, the most severe category indicating serious risk of injury or death. According to the agency’s February 21 announcement, the recall was motivated by a manufacturing issue that could…

Read More

Editor’s Note Backdoors in Chinese-made medical monitors could put patients at risk and compromise hospital networks across the US, according to security agencies quoted in a February 23 report from CNBC. The article cites the popular Contec CMS8000 patient monitor as an example. Both the US Food and Drug Administration…

Read More

Editor’s Note Preoperative use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) does not increase the risk of postoperative diabetic ketoacidosis (DKA) in patients undergoing emergency surgery, according to a study published February 19 in JAMA Surgery. These findings challenge the current FDA recommendation to withhold SGLT2i medications for at least three…

Read More

Editor's Note AI-generated operative reports for robotic-assisted radical prostatectomy (RARP) were more accurate than those written by surgeons in a study published February 7 in the Journal of the American College of Surgeons. Analyzing 158 cases from a tertiary referral center, researchers tested an AI computer-vision algorithm on surgical video…

Read More